NCT01910779 Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks Status UNKNOWN Phase NA
NCT01898910 Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation Status COMPLETED Phase PHASE2
NCT01898221 Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT01897545 Combined Treatment of Arterial Hypertension and Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT01896570 Role of Subsequent Atrial Tachycardia in Mechanisms of Persistent AF Status COMPLETED Phase N/A
NCT01896297 Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function Status COMPLETED Phase PHASE4
NCT01891058 Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED Status COMPLETED Phase NA
NCT01887353 The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure Status TERMINATED Phase PHASE2
NCT01878981 Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China Status COMPLETED Phase N/A
NCT01873352 Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT01871194 An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®). Status COMPLETED Phase N/A
NCT01858779 Know Your Pulse Post Stroke-Measurement of Peripheral Pulse for Detection of Atrial Fibrillation After Ischemic Stroke Status COMPLETED Phase N/A
NCT01857050 Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins Status COMPLETED Phase N/A
NCT01855139 Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism Status COMPLETED Phase N/A